Atnaujinkite slapukų nuostatas

Supplementary Protection Certificates (SPC) 2nd edition [Kietas viršelis]

Edited by (Maiwald Patentanwalts- und Rechtsanwalts-GmbH Munich, Germany)
  • Formatas: Hardback, 352 pages, aukštis x plotis x storis: 252x172x60 mm, weight: 1800 g
  • Išleidimo metai: 18-Nov-2021
  • Leidėjas: Hart Publishing
  • ISBN-10: 1509957219
  • ISBN-13: 9781509957217
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 352 pages, aukštis x plotis x storis: 252x172x60 mm, weight: 1800 g
  • Išleidimo metai: 18-Nov-2021
  • Leidėjas: Hart Publishing
  • ISBN-10: 1509957219
  • ISBN-13: 9781509957217
Kitos knygos pagal šią temą:

This commentary offers the definitive guide to supplementary protection certificates (SPC); a key element in the regulation of the pharmaceutical and medical market within Europe. Beyond providing an overview of the European legislation and the CJEU case-law on SPCs, it also depicts and summarises national law and jurisprudence on leading pharmaceutical markets such as Germany, France and the United Kingdom as well as The Netherlands, Italy and Switzerland.

Patent lawyers, those practising in the medical and pharmaceutical field as well as judges and academics will find this an invaluable resource.

Daugiau informacijos

Rigorous sets out the regime regulating Supplementary Protection Certificates (SPCs) in the medical and pharmaceutical sectors
Foreword v
List of Authors
xi
Abbreviations xiii
Part I Generals of the Supplementary Protection Certificate in the European Law
A Purpose, History and Legal Character of the Certificate
4(9)
I Overview
4(2)
II Relationship between Grant of the Patent and Authorisation under Pharmaceutical Law
6(4)
III History
10(1)
IV Legal Character
11(2)
B Substantive Granting Prerequisites
13(19)
I General
13(1)
II Product
13(2)
III Basic Patent
15(10)
IV First Marketing Authorisation
25(5)
V No Earlier Certificate -- Multiple SPCs for the Same Product
30(2)
C Calculation of Term
32(6)
I General
32(1)
II Relevant Date for the Calculation of Term
33(3)
III Negative Terms
36(2)
D Subject Matter
38(1)
E Scope of Protection
39(3)
I Rights of the Certificate Holder
39(2)
II Limitations and Obligations
41(1)
F Specific Practical Problems
42(15)
I Scope of Protection: "Salt Issue"
42(1)
II First Marketing Authorisation: Use Patents
43(4)
III Substance Combinations
47(10)
G Grant Procedure
57(8)
I General
57(1)
II Application
57(6)
III Grant and Announcement
63(1)
IV Fees to Maintain the SPC
64(1)
H Expiry, Invalidity and Revocation
65(3)
I Reasons for Expiry
65(1)
II Reasons for Invalidity
66(1)
III Revocation of a Term Extension
67(1)
IV Announcement
67(1)
J Remedies
68(1)
K Recent Developments
69(28)
I Intentions to Revise and Amendments to the RegSPC
69(14)
II Calls for the Creation of SPC Regulations for Other Products
83(6)
III Accession of New Member States to the European Union
89(5)
IV Withdrawal of the United Kingdom from the European Union
94(3)
Part II Specialities of National Jurisdictions
L The SPC in Germany
97(14)
I National Pharmaceutical and Patent Law
97(1)
II Application of the Art. 3 RegSPC Conditions
98(6)
III Calculation of the Term of the SPC
104(1)
IV Rights, Limitations and Obligations
104(1)
V SPC Grant, Termination and Remedies
105(6)
M The SPC in the United Kingdom
111(26)
I National Law relating to SPCs
111(5)
II Application of the Art. 3 RegSPC Conditions
116(15)
III SPC application procedure
131(4)
IV Transitional Provisions relating to Pre-existing SPCs and Applications from before or during the Transitional Period
135(1)
V Invalidation of SPCs and/or SPC Extensions
136(1)
N The SPC in France
137(10)
I French National Patents and Pharmaceutical Law
137(1)
II The Conditions for Obtaining an SPC
138(4)
III Grant Procedure for SPCs in France
142(2)
IV Scope of Protection
144(1)
V Duration of SPCs
144(1)
VI Waiver of SPCs
145(1)
VII Paediatric Extensions
145(2)
O The SPC in Italy
147(9)
I National Pharmaceutical and Patent Law
147(2)
II SPC Obtaining Provisions and Term
149(2)
III Subject Matter and Scope of Protection
151(1)
IV Rights, Limitations and Obligations
152(1)
V SPC Grant, Termination and Remedies
153(3)
P The SPC in The Netherlands
156(9)
I National Pharmaceutical and Patent Law
156(1)
II SPC Obtaining Provisions and Term in the Dutch Context
157(3)
III Substantive Requirements
160(2)
IV Rights, Limitations and Obligations
162(1)
V License
163(1)
VI Termination and Remedies
163(1)
VII Court Proceedings
164(1)
Q The SPC in Switzerland
165(20)
I Sources of Law and Legislative History
166(2)
II Substantive Granting Prerequisites
168(7)
III Subject-Matter of Protection and Effects
175(2)
IV Term of Protection
177(3)
V SPC for Plant Protection Products
180(1)
VI Application, Fees, Examination and Remedies
181(2)
VII Nullity
183(1)
VIII Swiss Federal Patent Court
184(1)
Annexes
A Selected Decisions of the European and National Case Law
185(68)
A1 Court of Justice of the European Union
185(27)
A2 German Courts
212(10)
A3 British Courts
222(10)
A4 French Courts
232(5)
A5 Italian Courts
237(2)
A6 Dutch Courts
239(3)
A7 Swiss Courts
242(11)
B Selected Legal Sources
253
B1 International Treaties
253(1)
B2 European Primary Law
254(5)
B3 European Regulations
259(24)
B4 European Directives
283(3)
B5 National Law
286
Marco Stief, attorney-at-law, is a partner at Maiwald Patentanwalts- und Rechtsanwalts-GmbH Munich, Germany.